A Safety Study of LY2886721 Single Doses in Healthy Subjects

Clinical trial NCT01133405 · COMPLETED

Trial details

NCT number: NCT01133405
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Alzheimer's Disease

Start date: 2010-06-01
Primary completion: 2010-10-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.